CAR-T CD19 for Acute Myeloid Leukemia with t(8;21) and CD19 expression
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CAR-T CD19 for Acute Myeloid Leukemia with t(8;21) and CD19 expression, covering 2023-11-28 to 2023-11-28. Get the full timeline:
Most recent: Clinical Trial Update: CAR-T CD19 for Acute Myelogenous Leukemia With t 8:21 and CD19 Expression [Phase 2, Phase 3]